je.st
news
Tag: patients
FDA Advisory Committee Recommends The Approval Of Lesinurad For Gout Patients
2015-11-03 04:41:07| drugdiscoveryonline Home Page
AstraZeneca recentlyannounced that the US Food and Drug Administration’s (FDA) Arthritis Advisory Committee (AAC) voted 10-4 to recommend the approval of lesinurad 200 mg tablets for the treatment of hyperuricemia associated with gout, in combination with a xanthine oxidase inhibitor (XOI)
Tags: committee
approval
patients
advisory
Mercks KEYTRUDA (pembrolizumab) Shows Superior Overall Survival Compared to Chemotherapy in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer Whose Tumors Express PD-L1
2015-10-26 14:00:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. Merck Plans Regulatory Submissions in the U.S. in late 2015 and in the European Union in Early 2016 KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced topline results from the KEYNOTE-010 study of KEYTRUDA (pembrolizumab) in advanced non-small-cell lung cancer (NSCLC) demonstrating that the trial met its primary objective. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558Courtney Ronaldo, 908-236-1108orInvestors:Teri Loxam, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: advanced
shows
express
cell
Fundraisers planned for two heart transplant patients with Chesapeake ties
2015-10-16 08:02:29| Paper - Topix.net
This story is a sample from the Chesapeake Clipper, which is included in The Virginian-Pilot every Sunday and Friday in Chesapeake. February is usually considered the time to think about matters of the heart.
Tags: heart
patients
planned
ties
Benefits of antiviral drugs for flu patients 'relatively small'
2015-10-08 01:33:29| Biotech - Topix.net
While most patients do not need the drug, more research is also needed on their use in pandemics, experts said. The report, from Academy of Medical Sciences and the Wellcome Trust, said antivirals can lead to a reduction in the duration of seasonal flu symptoms by between 14 and 17 hours.
Tags: small
benefits
patients
drugs
Results from Mercks Phase 3 Study of Investigational Chronic Hepatitis C Therapy Elbasvir/Grazoprevir in Patients with Advanced Chronic Kidney Disease Published in The Lancet
2015-10-06 01:01:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the publication of results from C-SURFER, the first Phase 31 clinical trial to investigate an all-oral, ribavirin-free chronic hepatitis C virus (HCV) treatment regimen in treatment-nave and treatment-experienced patients with advanced chronic kidney disease (CKD) stages 4 or 5 and chronic HCV genotype 1 (GT1) infection. Language: English Contact: MerckMedia Contacts:Doris Li, 908-246-5701Sarra Herzog, 201-669-6570orInvestor Contacts:Teri Loxam, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Sites : [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] next »